NIH Cuts Threaten to Cede U.S. Life Science Dominance to China
NIH funding is critical to maintaining American competitiveness and economic success. The Trump Administration’s proposed cuts to NIH’s indirect cost reimbursement threaten to undermine American exceptionalism, ceding our leadership in life sciences, global health, and biosecurity to China.
In an op-ed for the Timmerman Report, Life Science Washington President and CEO Marc Cummings and other state biotech association leaders call on the Trump Administration to drop the case regarding NIH cuts and start a meaningful dialogue with industry and research leaders to maintain our position as the world’s dominant life science powerhouse.